Investig Clin Urol.  2020 Mar;61(2):127-135. 10.4111/icu.2020.61.2.127.

Targeted next-generation sequencing for locally advanced prostate cancer in the Korean population

Affiliations
  • 1Department of Urology, Seoul National University College of Medicine, Seoul, Korea. mdrafael@snu.ac.kr
  • 2Department of Urology, SMG-SNU Boramae Medical Center, Seoul, Korea.
  • 3Department of Biomedical Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.

Abstract

PURPOSE
This study aimed to evaluate the feasibility of pan-cancer panel analysis for locally advanced prostate cancer in the Korean population.
MATERIALS AND METHODS
We analyzed 20 patients with locally advanced prostate cancer who underwent radical prostatectomy. A pan-cancer panel (1.9 Mbp) developed by Seoul National University Hospital (SNUH), composed of 183 target genes, 23 fusion genes, and 45 drug target regions was used for this analysis. We compared the SNUH pan-cancer panel results with The Cancer Genome Atlas (TCGA) database to search for different mutations in the Korean population. Clinical data were analyzed with univariate and multivariate analysis, and p-values <0.05 were considered statistically significant. Kaplan-Meier curve and log-rank tests were performed to evaluate survival.
RESULTS
The average age of the patients and initial prostate-specific antigen values were 69.3±7.8 years and 66.3±16.9 ng/dL, respectively. Average sequencing depth was 574.5±304.1×. Ninety-nine genetic mutations and 5 fusions were detected. SPOP (25%), KMT2D (20%), and BRAF (15%) were frequently detected. ERG fusions were recurrently detected in 20% of the patients, with SLMAP and SETD4 as novel fusion partners. BRAF mutation was frequently detected in this study, but not in the TCGA database. Multivariate analysis showed BRAF mutation as an independent prognostic factor for biochemical recurrence (hazard ratio, 9.84; p=0.03).
CONCLUSIONS
The pan-cancer panel comprising genes related to prostate cancer is a useful tool for evaluating genetic alterations in locally advanced prostate cancers. Our results suggest that the BRAF mutation is associated with biochemical recurrence in the Korean population.

Keyword

Genetics; Prostate-specific antigen; Prostatic neoplasms; Recurrence

MeSH Terms

Genetics
Genome
Humans
Multivariate Analysis
Prostate*
Prostate-Specific Antigen
Prostatectomy
Prostatic Neoplasms*
Recurrence
Seoul
Prostate-Specific Antigen
Full Text Links
  • ICU
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error